"The initial multi-pallet order is already en route to the U.S. Virgin Islands, and we have reserved The Wild Ecology's regular order in our production schedule," said Joel Fruendt, the President and CEO of SenesTech. PHOENIX, June 26, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announced that Evolve™, the Company's minimum risk soft bait for the proactive control of rats, will be deployed in the ...

SenesTech, Inc. (SNES) , a player in the field of fertility control for managing animal pest populations, has announced the launch of its Evolve fertility control solution for rats on Amazon (AMZN) . This strategic move marks a significant advancement in the distribution of Evolve, the company's innovative minimum-risk soft bait designed for proactive rat control. More on Evolve Unlike traditional methods that rely heavily on poisons, Evolve targets the root cause of rodent overpopulation by reducing fertil ...

The webcasted presentation will take place at 11:45am ET on Thursday, May 30, 2024. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2024/ or directly at https://wsw.com/webcast/lytham11/snes/2110185. The webcast will also be available for replay following the event. PHOENIX, May 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) today announced that Joel Fruendt, Chief Executive Officer, and Tom Chesterman, Chief Financial Officer, will participate i ...

PHOENIX, May 22, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announced that it has taken a significant step forward in the distribution of EvolveTM, the Company's minimum risk soft bait for the proactive control of rats, through the launch of a dedicated online store on Amazon, the world's largest online retailer. To purchase Evolve on Amazon, please visit this link. "Evolve isn't just a product; ...

Financial Data and Key Metrics Changes - Revenue during the first quarter was $415,000, an increase of 78% compared to $233,000 in Q1 of 2023, and a 41% increase sequentially from Q4 of 2023 [35][49] - Net loss during the quarter was $1.8 million compared to a net loss of $2 million in Q1 of 2023, an improvement of $200,000 [38] - Adjusted EBITDA loss for Q1 of 2024 was $1.7 million compared to $1.8 million in Q1 of 2023, marking the smallest quarterly adjusted EBITDA loss in company history [38] Business Line Data and Key Metrics Changes - Evolve, the new soft bait product, contributed more than 50% of first quarter revenue, indicating its significant impact on sales [9][35] - The company has expanded manufacturing capabilities to meet demand, with current capacity at about 1,000 pounds per day, soon to increase to 2,000 pounds, and a clear path to 4,000 pounds per day [36] Market Data and Key Metrics Changes - The introduction of Evolve has effectively doubled the addressable market opportunity, with U.S. rodent and pest management product sales exceeding $1 billion annually [28][51] - The international channel has seen substantial interest, with six key international exclusive distribution agreements signed since Evolve's launch [29] Company Strategy and Development Direction - The company is focusing on a six-channel strategy for distribution, including e-commerce, international, agribusiness, pest management, industrial, and retail [52] - A significant opportunity has been identified in the industrial channel, with agreements being finalized for an industrial rep agency to assist in distribution [5] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the acceptance of Evolve by remaining states, which is expected to accelerate growth in Q2 [3] - The company is optimistic about the potential for Evolve to become the product of choice for rodent population control, especially as regulatory approvals expand [4][16] Other Important Information - The company has expanded its warehouse space in Phoenix to accommodate increased raw materials and finished goods [19] - Evolve has been designed to address the root cause of rodent overpopulation, focusing on reproductive control rather than traditional extermination methods [34] Q&A Session Summary Question: What should we expect in the coming quarter for the mouse product sales outlook? - Management is in contact with major pest control companies and anticipates that as Evolve proves effective in the field, these companies will consider supply agreements [42] Question: Do you expect the Amazon store to cannibalize sales from your own website? - Management believes that the Amazon channel will be strong, but customers will still prefer to buy directly from the company, indicating a neutral pricing strategy [45]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-37941 SENESTECH, INC. (Exact name of registrant as specified in its charter) | Delaware | 20-2079805 | ...

Exhibit 99.1 SenesTech Announces First Quarter 2024 Financial Results PHOENIX, Ariz., May 9, 2024. SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control products today announced financial results for the first quarter of 2024. ® Recent Highlights Management Discussion "I am extremely pleased with the rapid revenue growth during the first quarter of 7 ...

SenesTech, Inc. (NASDAQ:SNES) Q4 2023 Earnings Conference Call February 21, 2024 5:00 PM ET Company Participants Robert Blum - Lytham Partners, IR Joel Fruendt - CEO Tom Chesterman - CFO Conference Call Participants Amit Dayal - H.C. Wainwright Operator Good afternoon, and welcome to the SenesTech Reports Fourth Quarter and Fiscal Year 2023 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded. I'd now like to turn the conference over to Robert Blum with Lytham ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37941 SENESTECH, INC. (Exact name of registrant as specified in its charter) FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR Indicate by check mark if the registr ...

Exhibit 99.1 SenesTech Announces 2023 Financial Results YTD 2024 total revenue up more than 80% compared to YTD 2023 driven by orders for Evolve soft bait TM PHOENIX, Ariz., February 21, 2024. SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced 2023 financial results. "During 2023, we executed on a number of key initiatives that will be the foundation t ...